Chronic Pulmonary Aspergillosis : Data
Chronic Pulmonary Aspergillosis (CPA) claims over 340,000 lives annually, with a recent study revealing its severe impact on individuals with pre-existing lung diseases.
- Chronic Pulmonary Aspergillosis (CPA) is a fungal infection of the lungs, caused by Aspergillus, a common type of mold.
- Aspergillus is commonly found in households, workplaces, and public spaces, as well as in outdoor areas.
- People who have chronic lung conditions, such as emphysema, bronchitis, or tuberculosis, are most at risk of developing CPA.
- CPA is not contagious.
- It cannot be passed from person to person.
- CPA doesn’t always cause symptoms in the early stages.
- When symptoms do occur, they can vary from person to person.
- The most common symptom of CPA is coughing up blood.
- For most people, CPA is a lifelong condition, and long-term management is needed. However, for a small number of people, CPA may sometimes resolve completely.
- Antifungal medications are the most common treatment for CPA.
- Surgery is an option to remove the fungal mass.
- This is done when CPA causes bleeding in the lungs.